Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin
Authors:
- 1 September 1993
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (9) , 1831-1834
Abstract
Quinolones have been reported to be active against Brucella species in vitro. In this prospective randomized study, the efficacy and safety of the combination of ofloxacin plus rifampin were compared with the efficacy and safety of doxycycline plus rifampin, both combinations administered for a 6-week period in treatment of brucellosis. Sixty-one patients were enrolled in the study, and 49 had blood or bone marrow cultures positive for Brucella melitensis. Thirty patients received 200 mg of doxycycline plus 600 mg of rifampin once daily, and 31 patients were treated with 400 mg of ofloxacin plus 600 mg of rifampin once daily for 6 weeks. Nine patients in each group had complications of the disease. There was one therapeutic failure in the ofloxacin-rifampin treatment group, and one patient from each group relapsed (3.3% of those in the doxycycline-rifampin treatment group versus 3.2% of those in the ofloxacin-rifampin treatment group). Gastric discomfort was the major side effect observed in 13 patients (43.3%) who received doxycycline plus rifampin, whereas only 2 patients (6.5%) treated with ofloxacin plus rifampin complained of gastric irritation. These results suggest that the combination of ofloxacin plus rifampin administered for 6 weeks is as effective as doxycycline plus rifampin given for the same period, regardless of the presence of complications of the disease.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy of ciprofloxacin for treatment of Brucella melitensis infectionsAntimicrobial Agents and Chemotherapy, 1992
- In vitro susceptibility of Brucella melitensis to antibioticsAntimicrobial Agents and Chemotherapy, 1991
- Lack of effective bactericidal activity of new quinolones against Brucella sppAntimicrobial Agents and Chemotherapy, 1991
- Failure of prolonged treatment with dprofloxadn in acute infections dueto Brucella melitensisJournal of Antimicrobial Chemotherapy, 1990
- Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensisAntimicrobial Agents and Chemotherapy, 1989
- Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational studyJournal of Antimicrobial Chemotherapy, 1989
- In vitro activity of ciprofloxacin againstBrucella melitensisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Brucellosis treated with rifampicin.Archives of Disease in Childhood, 1980
- Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility TestsThe Journal of Infectious Diseases, 1977
- OXYTETRACYCLINE-STREPTOMYCIN THERAPY IN BRUCELLOSIS DUE TO BRUCELLA MELITENSISArchives of internal medicine (1960), 1953